Version 3 Launch
Intravenous has launched version 3 of the site today — a massive redesign. Almost all of the visual aesthetics have been improved as well as functionality adjustments.
If you had an account on the old site, simply register on the new site and all your existing articles and comments will be moved to your account within a day. Please do not register an account normally AND do Facebook Connect — this will create two accounts. Use one or the other depending on how you prefer to login.
- The front page displays a slideshow of featured articles at the top, and below, the most recent article from 3 different categories is displayed. At the bottom is a listing of the most recent articles sitewide.
- You can now register an account and login by simply connecting your existing Facebook account. Just click the blue connect button below the login form.
- Every article now has an associated image. You may choose a specific photo for your own articles or allow us to choose one for you. The article submission form is much easier to use. In addition, if you are are not logged in, you are reminded to login, to create an account, or to submit as a guest
- At the end of every article is a listing of recent articles from the same author
- Profiles are now linked to author names. Profile pictures can be uploaded as well as other features such as friend requests, groups, and messaging.
- A mobile interface is now accessible when browsing the site on a supported device.
We hope you will explore the site and continue to publish your writing. Because we are a relatively young endeavor, we require incessant promotion to be successful. The future of Intravenous depends on your enthusiasm.
We will soon release a packet of instruction for promotion to School Representatives at various high schools and colleges. If you are interested in becoming your school’s representative, please contact William Johnston at williamjohnston@ivwriting.com.
We cannot thank you enough for your contribution to Intravenous. If you have any questions, comments, or feedback, please contact us.












